Shaping Futures: Pharmacy's Role in Pediatric Obesity

Pharmacist CEU
notesMonograph
Contact Hours: 2.0 (0.2 CEUs)

Course Summary

Recent studies indicate that nearly one in five children and adolescents in the United States are affected by obesity, setting the stage for a potential health crisis. As obesity rates rise in the pediatric population, so do other medical conditions and chronic diseases. They include asthma, sleep apnea, fatty liver disease, gallstones and gallbladder disease, cardiovascular diseases, joint problems, menstrual abnormalities, metabolic diseases, and skin diseases. These conditions were more commonly seen in adulthood in prior decades. Not surprisingly, pediatric obesity leads to obesity in adulthood. Pharmacists and pharmacy technicians with a deep understanding of the diagnosis and screening, physical and mental burden, and available treatment options for obesity can make a significant difference in care and outcomes for this vulnerable patient population.


Course Objectives

Discuss the growing prevalence and burden of pediatric obesity

Describe the immediate and long-term risks of obesity in childhood and adolescence

Demonstrate the pharmacy team’s role in optimizing care for pediatric patients with obesity


I. Introduction

II. Prevalence of Pediatric Obesity

III. Obesity Diagnosis and Screening in Pediatrics

IV. Causes of Childhood Obesity

V. Defining the Burden of Pediatric Obesity

1. Physical Health Consequences
2. Mental Health Impact

VI. Managing Pediatric Obesity

1. Lifestyle and Dietary Changes
2. Pharmacologic Treatment
3. Metabolic and Bariatric Surgery

VII. The Pharmacy Team’s Role in Pediatric Obesity

1. Drug Utilization Review
2. Referrals for Specialized Care
3. Counseling and Education
4. Inventory Management

VIII. Summary

How to Earn Credit:
To earn credit for this course, participants must:
  1. Read the course objectives and faculty planner disclosure
  2. Read the course material
  3. Complete the post-test with a minimum score of 70% and complete the course evaluation form.
  4. Results are automatically submitted to CPE Monitor

Faculty Planner Disclosure

The following individuals were involved in developing this activity: Kelsey Giara, PharmD, RPh, and Pamela Sardo, PharmD, BS. Pamela Sardo was an employee of Rhythm Pharmaceuticals until March 2022 and has no conflicts of interest or relationships regarding the subject matter discussed. There are no financial relationships relevant to this activity to report or disclose by any of the individuals involved in the development of this activity.


Unlabeled Use Disclosures

The information provided in this course is general in nature and it is solely designed to provide participants with continuing education credit(s). This course and materials are not meant to substitute for the independent, professional judgment of any participant regarding that participant’s professional practice, including but not limited to patient assessment, diagnosis, treatment and/or health management. Medical and pharmacy practices, rules, and laws vary from state to state, and this course does not cover the laws of each state; therefore, participants must consult the laws of their state as they relate to their professional practice. Healthcare professionals, including pharmacists and pharmacy technicians, must consult with their employer, healthcare facility, hospital, or other organization, for guidelines, protocols, and procedures they are to follow. The information provided in this course does not replace those guidelines, protocols, and procedures but is for academic purposes only, and this course’s limited purpose is for the completion of continuing education credits. Participants are advised and acknowledge that information related to medications, their administration, dosing, contraindications, adverse reactions, interactions, warnings, precautions, or accepted uses are constantly changing, and any person taking this course understands that such person must make an independent review of medication information prior to any patient assessment, diagnosis, treatment and/or health management. Any discussion of off-label use of any medication, device, or procedure is informational only and such uses are not endorsed hereby. Nothing contained in this course represents the opinions, views, judgments, or conclusions of RxCe.com LLC. RxCe.com LLC is not liable or responsible to any person for any inaccuracy, error, or omission with respect to this course, or course material.

Computer Hardware/Software Requirements

Please ensure the device you plan to use meets these requirements and specifications:

  • Operating System: Windows 7,8,10, or 11 /Mac OS X 10.9 or later/iOS/Android
  • Supported Browsers: Microsoft Edge, Firefox, Google Chrome, Safari, Opera
  • A connection to the internet
  • For Live Webinars or Conferences: GoToWebinar application for iOS, Android, Mac, or PC. You cannot 'call into' a live conference.

  • Target Audience: Pharmacist
  • Contact Hours: 2.0 (0.2 CEUs)
  • Activity Release Date: 11/18/2023
  • Activity Expiration Date: 11/18/2026
  • Activity Type: Knowledge
  • UAN: 0669-0000-23-187-H01-P
  • Topic: Disease State Management/Drug Therapy
  • CeBroker Number: 20-1129518

Author:

Kelsey Giara, PharmD, RPh

AUTHOR BIO

VIEW PDF VIEW AS WEB PAGE

The logo for the Accreditation Council for Pharmacy Education (ACPE).

RxCe.com, LLC is accredited by the Accreditation Council for Pharmacy Education as a provider of continuing pharmacy education.

‹‹ Back to Course List